Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines.
about
Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metaboliteAlprazolam intercalates into DNA.Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis.Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene.Classics in chemical neuroscience: diazepam (valium).Clinically significant psychotropic drug-drug interactions in the primary care setting.Efficacy and cost analysis of transrectal ultrasound-guided prostate biopsy under monitored anesthesia.Epigenetic and microRNA-dependent control of cytochrome P450 expression: a gap between DNA and protein.Pharmacogenetic considerations in the treatment of psychiatric disorders.Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm.Do we need pharmacogenetics to personalize antidepressant therapy?The safety and tolerability of intranasal midazolam in epilepsy.The emergence of new psychoactive substance (NPS) benzodiazepines: A review.Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics.Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study.Role of CYP2C19 gene polymorphism in acute alcohol withdrawal treatment with loading dose of diazepam in a South Indian population.
P2860
Q28472957-4A1421FE-0384-44C3-800E-A3DB985B7068Q33395805-8F120166-7869-46AD-9908-050E2184C41EQ33602525-0767BDC1-C1B1-4AEE-B565-04398803C0EEQ33652540-036452B2-D3C4-4634-B4BE-B362EB236D04Q34405394-AFF724E7-4AE4-445E-B797-272D39F486ECQ35104220-83815407-6C93-4A6E-BE6D-13C885E94AC5Q37085267-50BE5465-1DD0-48BC-9CFE-83011B391D63Q37551896-90381438-A623-43FC-A8F2-2332C2E325E3Q37681573-7127635B-894E-4B13-85C4-7AC986B51D64Q38040844-BF2CCF91-B759-4F7E-8A9F-3429D21CDA0BQ38070163-346790C9-F50D-4F69-B56A-114257142D7FQ38218631-1507ACF6-F192-4111-A2BC-18FEB3F40694Q39282924-2DCD2FA2-E03F-44B7-8B31-017AA4145D66Q43720103-B873E077-27A8-4832-B6B3-F4FD19B657F1Q43759147-ED7B1CBE-42C6-4963-ABEE-03921212EEE1Q44760870-C59ACB6E-FA1E-4517-BC81-E251201A4F24Q47438997-1F1B1CD5-56AF-4C43-89CC-8741308D9B22
P2860
Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Effects of genetic polymorphis ...... cokinetics of benzodiazepines.
@en
type
label
Effects of genetic polymorphis ...... cokinetics of benzodiazepines.
@en
prefLabel
Effects of genetic polymorphis ...... cokinetics of benzodiazepines.
@en
P2093
P2860
P1476
Effects of genetic polymorphis ...... cokinetics of benzodiazepines.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2710.2007.00829.X
P577
2007-08-01T00:00:00Z